Physician profile
Patrick P Bunyi
NPI 1871518787
$8,317.64
in general payments reported to CMS, 2019-2025
41 companies · $513 in 2025
The $513 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,766 · 2020: $1,028 · 2021: $1,854 · 2022: $970 · 2023: $982 · 2024: $1,205 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,699.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,648.28 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $928.85 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $821.52 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $641.95 | 2019-2023 | Ozempic, Rybelsus |
| Lilly USA, LLC | $567.70 | 2019-2024 | Mounjaro, Jardiance, Emgality |
| Indivior INC. | $425.23 | 2019-2025 | Sublocade |
| Allergan, INC. | $389.87 | 2019-2020 | |
| Abbvie INC. | $316.58 | 2021-2025 | Vraylar |
| Pfizer INC. | $273.52 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $251.84 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $225.34 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $217.20 | 2022-2024 | |
| Abbott Laboratories | $171.83 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.69 | 2019-2024 | Jardiance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $123.29 | 2024-2025 | Caplyta |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Bunyi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.